… is to understand the drug–drug interaction (DDI) potential of a drug, acting either as victim
or perpetrator when used along with other medications. When such an interaction is present, it …

… However, polypharmacy increases the risk of experiencing ADRs due to drug–drug interactions
and interactions between drugs and the patient’s underlying medical conditions and this …

… Recently, PGP has been implicated as the causative factor in numerous pharmacokinetic
drug interactions.[19] For example, amiodarone and quinidine increase serum digoxin …

… of anticancer drugs and contribute to optimizing drug dosing regimens, predicting drug
response, and identifying potential drug interactions or toxicities. These modeling approaches …

… have been used to study drug interactions and the effect of disease on drug metabolism [23–…
collect blood samples in order to study drug interactions of clinical significance in children. …

… Adaptive electronic based guidelines that allow interactive searching for specific conditions
are a potential way forward to account for multimorbidity in guideline recommendations …

… Insufficient metabolite generation secondary to limitations in intestinal absorption, Drug-drug
interaction at CYP 3A4 or genetic polymorphism of CYP isoenzymes are seen as the …

… abscessus, we summarize the current state of NTM drug discovery and development, … in
NTM drug discovery and discuss how to focus research efforts to accelerate building a NTM drug …

… in vivo pharmacokinetic drug-drug interaction studies targeted to … Drug-drug interactions can
lead to severe side effects and … Regulators, including the US Food and Drug Administration (…

… drug interactions, monitor its safety and eventually stop its administration). Adapting
pharmacological therapy to each patient is an advanced skill for medical students and represents a …